Table HSR-5. Syringe provision [see all tables in this series...]

Part (ii) Syringes distributed, exchanged or sold and individual clients and client contacts at specialist agencies with NSPs, 2007

Country		Number syringes (x 1000)	% of NSPs reporting number of syringes	Number of clients		% of NSPs reporting client numbers	Number of client contacts		% of NSPs reporting client contacts
Belgium (Flemish community)		501	85				16872		100
Belgium (French community)		321	100	:		:	:		:
Bulgaria	(2)	735	100	6137	(1)	100	44250		90
Czech Republic	(2)	4457	100	27200	(1)	80	338000	(1)	80
Denmark		:	:	:		:	:		:
Germany		:	:	:		:	:		:
Estonia		1966	100	:		:	193503		89.6
Ireland	(3)	1097	72	7069		76	:		:
Greece	(4)	35	100	497		25	6006		75
Spain		3486	:	:		:	:		:
France	(5)	4800	98	40000	(1)	100	:		:
Italy		:	:	:		:	:		:
Cyprus		0.005	100	:		:	:		:
Latvia	(6)	126	100	1939	(1)	100	25385		100
Lithuania	(2)	187	100	3399	(1)	100	43856	(1)	100
Luxembourg		267	100	:		:	:		:
Hungary	(2)	187	100	2019		100	27967		100
Malta		226	:	:		:	:		:
Netherlands		380	:	:		:	:		:
Austria	(7)	2959	99	:		:	:		:
Poland	(2)	396	100	3230		100	41272		100
Portugal	(8)	971	100	8761		100	123784		100
Romania	(4)	1232	100	4112	(1)	100	15900	(1)	100
Slovenia		857	100	:		:	:		:
Slovakia	(9)	454	77	4200	(1)	77	44689		77
Finland	(2)	2648	100	13000		100	92000		100
Sweden	(10)	117	100	1230		100	15404		100
UK- England&Wales		:	:	:		:	:		:
UK-Northern Ireland		:	:	:		:	:		:
UK-Scotland		:	:	:		:	:		:
Croatia	(2)	138	100	3201		100	12878		100
Turkey		0	:	0		:	0		:
Norway		3275	42

Notes:

 The number of syringes includes fixed and mobile needle and syringe programme points and in the community (but not including pharmacy-based programmes, vending machines and prison NSPs). 

 Where data are not available, the table entry is left empty.     

 Double counting of clients and contacts can in most countries not be excluded and syringe rates per client or contact might often be underestimates. 

 (1) Numbers provided are estimates.     

 (2) Individual client using services at specialist drugs agency with NSP at least once in the reporting year; not limited to use of syringe exchange. Double-counting controls at agency level. 

 (3) Individually registered NSP clients.  

 (4) Individuals who approached the needle and syringe programmes; use of unique identifiers.  

 (5) Estimated total number of drug users who used specialised harm reduction facilities (CAARUD) during the reporting year, based on 1-week client survey; not limited to use of syringe exchange. 

 (6) Monitoring system of all clients using low-threshold HIV prevention centres. 

 (7) Case definition ("client") differs between agencies regarding the required minimum number of contacts per person. 

 (8) Case definition ("client"): drug users regularly assisted by the intervention of outreach teams. 

 (9) The 'client' case-definition used is: a drug user who have used at least once services of the agency in a given year. Not in all reporting agencies double-counting procedures are in place nor double-counting checks at higher level (geographical unit, national level) are available. 

 (10) The 'client' case-definition used is: a person of 20 years or older living in Skane county, and with a documented injection misuse. These are the criteria according to the Swedish Act of Needle and Syringe exchange (SF 2006:323) and the regulations about needle and syringe exchange from the National Board of Health and Welfare (SOSFS 2007:2). 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Standard tables on 'syringe availability' (ST10) submitted by NFPs in 2008. 

 Reitox National Reports 2008. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)